Bridging Drug Delivery and Molecular Biology: A Synergistic Alliance between Liposomes and Bioinformatics

Authors

  • Mehral Aslam Department of Biotechnology, Lahore College for Women University, Lahore-Pakistan https://orcid.org/0009-0000-4298-3998
  • Sadia Iftikhar Department of Biotechnology, Lahore College for Women University, Lahore-Pakistan
  • Mazia Amber School of Biological Sciences, Queen’s University Belfast, United Kingdom (UK)
  • Jawad Amin Department of Horticulture, University of Sargodha, Sargodha-Pakistan
  • Khazeema Yousaf Department of Biotechnology, Lahore College for Women University, Lahore-Pakistan
  • Qurat ul Ain Department of Microbiology and Molecular Genetics, University of Okara, Pakistan
  • Erum Naz Malir University of science and Technology, Karachi Pakistan

DOI:

https://doi.org/10.38211/jms.2024.03.157

Abstract

Liposomes, since their discovery have emerged as valuable nanocarriers in drug delivery and molecular biology, significantly enhancing the therapeutic index of many drugs. They were first coined in early 1960s by discovery by Bangham and co-workers. Beyond their conventional applications, a growing interest lies in integrating liposome technology with bioinformatics. Bioinformatic tools plays an important role in predicting, analyzing and simulating complex biological processes. These tools offer deeper insights into liposomal interactions with biological systems. Thanks to this advanced computational modeling, scientists can now design liposomes with improved targeting abilities, optimized stability, and enhanced therapeutic potential. One such model i.e Quantitative Structure–Activity Relationship (QSAR) is used for the precise prediction of liposome–drug and liposome–cell interactions, ultimately contributing to higher drug efficacy and reduced adverse effects. Many studies conducted till date throw light upon the promising synergy between liposomes and bioinformatics, highlighting its potential to transform drug delivery. This review explores this integration, focusing on how computational approaches can advance liposomal design, precision, and efficiency in therapeutic applications

References

Abbasi, H., Kouchak, M., Mirveis, Z., Hajipour, F., Khodarahmi, M., & others. (2022). What we need to know about liposomes as drug nanocarriers: An updated review. Advanced Pharmaceutical Bulletin, 13(1), 7. https://doi.org/10.34172/apb.2023.007 DOI: https://doi.org/10.34172/apb.2023.009

Hamid, M. S. S., Hatwar, P. R., Bakal, R. L., & Kohale, N. B. (2024). A comprehensive review on liposomes: As a novel drug delivery system. GSC Biological and Pharmaceutical Sciences, 27(1), 199–210. https://doi.org/10.30574/gscbps.2024.27.1.0121 DOI: https://doi.org/10.30574/gscbps.2024.27.1.0121

Li, M., Du, C., Guo, N., Teng, Y., Meng, X., Sun, H., & others. (2019). Composition design and medical application of liposomes. European Journal of Medicinal Chemistry, 164, 640–653. https://doi.org/10.1016/j.ejmech.2019.01.007 DOI: https://doi.org/10.1016/j.ejmech.2019.01.007

Najlah, M., Said Suliman, A., Tolaymat, I., Kurusamy, S., Kannappan, V., Elhissi, A., & Wang, W. (2019). Development of injectable PEGylated liposome encapsulating disulfiram for colorectal cancer treatment. Pharmaceutics, 11(11), 594. https://doi.org/10.3390/pharmaceutics11110610 DOI: https://doi.org/10.3390/pharmaceutics11110610

Kanamala, M., Palmer, B. D., Jamieson, S. M., Wilson, W. R., & Wu, Z. (2019). Dual pH-sensitive liposomes with low pH-triggered sheddable PEG for enhanced tumor-targeted drug delivery. Nanomedicine, 14(15), 1971–1989. https://doi.org/10.2217/nnm-2018-0510 DOI: https://doi.org/10.2217/nnm-2018-0510

Mohamed, M., Abu Lila, A. S., Shimizu, T., Alaaeldin, E., Hussein, A., Sarhan, H. A., & others. (2019). PEGylated liposomes: Immunological responses. Science and Technology of Advanced Materials, 20(1), 710–724. https://doi.org/10.1080/14686996.2019.1627174 DOI: https://doi.org/10.1080/14686996.2019.1627174

Gagliardi, M., & Ashizawa, A. T. (2021). The challenges and strategies of antisense oligonucleotide drug delivery. Biomedicines, 9(4), 433. https://doi.org/10.3390/biomedicines9040433 DOI: https://doi.org/10.3390/biomedicines9040433

Aghanejad, A., Omidian, H., & Omidi, Y. (2021). Medical applications of multifunctional magnetic nanoparticles. In A. Ehrmann, T. A. Nguyen, M. Ahmadi, A. Farmani, & P. Nguyen-Tri (Eds.), Magnetic nanoparticle-based hybrid materials (pp. 447–462). Woodhead Publishing. https://doi.org/10.1016/B978-0-12-823688-8.00001-6 DOI: https://doi.org/10.1016/B978-0-12-823688-8.00001-6

Patel, S., & Ghosh, A. (2022). Integrating computational modeling with liposomal drug delivery systems. Journal of Drug Targeting, 30(4), 406–419. https://doi.org/10.1080/1061186X.2021.1966691

Sharma, D., Ali, A. A. E., & Trivedi, L. R. (2018). An updated review on: Liposomes as drug delivery system. PharmaTutor, 6(2), 50–62. https://doi.org/10.29161/PT.v6.i2.2018.50 DOI: https://doi.org/10.29161/PT.v6.i2.2018.50

Nakhaei, K., Bagheri-Hosseini, S., Sabbaghzade, N., Behmadi, J., & Boozari, M. (2023). Boswellic acid nanoparticles: Promising strategies for increasing therapeutic effects. Revista Brasileira de Farmacognosia, 33(4), 713–723. https://doi.org/10.1007/s43450-023-00405-7 DOI: https://doi.org/10.1007/s43450-023-00405-7

Gonda, A., Zhao, N., Shah, J. V., Calvelli, H. R., Kantamneni, H., Francis, N. L., & Ganapathy, V. (2019). Engineering tumor-targeting nanoparticles as vehicles for precision nanomedicine. Med One, 4, e190021. https://doi.org/10.20900/mo.20190021

Liu, P., Chen, G., & Zhang, J. (2022). A review of liposomes as a drug delivery system: Current status of approved products, regulatory environments, and future perspectives. Molecules, 27(4), 1372. https://doi.org/10.3390/molecules27041372

Aslam, M., Iqtedar, M., Saeed, H., Abdullah, R., & Kaleem, A. (2022). Formulation and characterization of ciprofloxacin encapsulated liposomes: In vitro antimicrobial activity against multi-drug resistant Salmonella typhi. Revista Mexicana de Ingeniería Química, 21(2), Bio2734. https://doi.org/10.24275/rmiq/Bio2734

Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022). Liposomes: Structure, composition, types, and clinical applications. Heliyon, 8(5), e09387. https://doi.org/10.1016/j.heliyon.2022.e09394 DOI: https://doi.org/10.1016/j.heliyon.2022.e09394

Lombardo, D., & Kiselev, M. A. (2022). Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics, 14(3), 543. https://doi.org/10.3390/pharmaceutics14030543 DOI: https://doi.org/10.3390/pharmaceutics14030543

Yan, W., Leung, S. S., & To, K. K. (2020). Updates on the use of liposomes for active tumor targeting in cancer therapy. Nanomedicine, 15(3), 303–318. https://doi.org/10.2217/nnm-2019-0308 DOI: https://doi.org/10.2217/nnm-2019-0308

Cauzzo, J., Jayakumar, N., Ahluwalia, B. S., Ahmad, A., & Škalko-Basnet, N. (2021). Characterization of liposomes using quantitative phase microscopy (QPM). Pharmaceutics, 13(5), 590. https://doi.org/10.3390/pharmaceutics13050590 DOI: https://doi.org/10.3390/pharmaceutics13050590

Fan, Y., Marioli, M., & Zhang, K. (2021). Analytical characterization of liposomes and other lipid nanoparticles for drug delivery. Journal of Pharmaceutical and Biomedical Analysis, 192, 113642. https://doi.org/10.1016/j.jpba.2020.113642 DOI: https://doi.org/10.1016/j.jpba.2020.113642

Torres-Flores, G., Gonzalez-Horta, A., Vega-Cantu, Y. I., Rodriguez, C., & Rodriguez-Garcia, A. (2020). Preparation and characterization of liposomal everolimus by thin‐film hydration technique. Advances in Polymer Technology, 2020(1), 5462949. https://doi.org/10.1155/2020/5462949 DOI: https://doi.org/10.1155/2020/5462949

Man, F., Gawne, P. J., & de Rosales, R. T. (2019). Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine. Advanced Drug Delivery Reviews, 143, 134–160. https://doi.org/10.1016/j.addr.2019.05.012 DOI: https://doi.org/10.1016/j.addr.2019.05.012

Almeida, B., Nag, O. K., Rogers, K. E., & Delehanty, J. B. (2020). Recent progress in bioconjugation strategies for liposome-mediated drug delivery. Molecules, 25(23), 5672. https://doi.org/10.3390/molecules25235672 DOI: https://doi.org/10.3390/molecules25235672

El-Hammadi, M. M., & Arias, J. L. (2019). An update on liposomes in drug delivery: A patent review (2014–2018). Expert Opinion on Therapeutic Patents, 29(11), 891–907. https://doi.org/10.1080/13543776.2019.1679767 DOI: https://doi.org/10.1080/13543776.2019.1679767

Pauli, G., Tang, W.-L., & Li, S.-D. (2019). Development and characterization of the solvent-assisted active loading technology (SALT) for liposomal loading of poorly water-soluble compounds. Pharmaceutics, 11(9), 465. https://doi.org/10.3390/pharmaceutics11090465 DOI: https://doi.org/10.3390/pharmaceutics11090465

Tamam, H., Park, J., Gadalla, H. H., Masters, A. R., Abdel-Aleem, J. A., Abdelrahman, S. I., et al. (2019). Development of liposomal gemcitabine with high drug loading capacity. Molecular Pharmaceutics, 16(7), 2858–2871. https://doi.org/10.1021/acs.molpharmaceut.8b01284 DOI: https://doi.org/10.1021/acs.molpharmaceut.8b01284

Pande, S. (2023). Liposomes for drug delivery: Review of vesicular composition, factors affecting drug release and drug loading in liposomes. Artificial Cells, Nanomedicine, and Biotechnology, 51(1), 428–440. https://doi.org/10.1080/21691401.2023.2247036 DOI: https://doi.org/10.1080/21691401.2023.2247036

Vakili-Ghartavol, R., Rezayat, S. M., Faridi-Majidi, R., Sadri, K., & Jaafari, M. R. (2020). Optimization of docetaxel loading conditions in liposomes: Proposing potential products for metastatic breast carcinoma chemotherapy. Scientific Reports, 10(1), 5569. https://doi.org/10.1038/s41598-020-62501-1 DOI: https://doi.org/10.1038/s41598-020-62501-1

Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021). Design of liposomes as drug delivery system for therapeutic applications. International Journal of Pharmaceutics, 601, 120571. https://doi.org/10.1016/j.ijpharm.2021.120571 DOI: https://doi.org/10.1016/j.ijpharm.2021.120571

Farooque, F., Wasi, M., & Mughees, M. M. (2021). Liposomes as drug delivery system: An updated review. Journal of Drug Delivery and Therapeutics, 11, 149–158. https://doi.org/10.22270/jddt.v11i5-S.5063 DOI: https://doi.org/10.22270/jddt.v11i5-S.5063

Basu, B., Prajapati, B., Dutta, A., & Paliwal, H. (2024). Medical application of liposomes. Journal of Exploratory Research in Pharmacology, 9(1), 13–22. https://doi.org/10.14218/JERP.2023.00002 DOI: https://doi.org/10.14218/JERP.2023.00002

Kumbham, S., Ajjarapu, S., Ghosh, B., & Biswas, S. (2023). Current trends in the development of liposomes for chemotherapeutic drug delivery. Journal of Drug Delivery Science and Technology, 87, 104854. https://doi.org/10.1016/j.jddst.2023.104854 DOI: https://doi.org/10.1016/j.jddst.2023.104854

Peng, T., Xu, W., Li, Q., Ding, Y., & Huang, Y. (2023). Pharmaceutical liposomal delivery—Specific considerations of innovation and challenges. Biomaterials Science, 11, 62–75. https://doi.org/10.1039/D2BM01252A DOI: https://doi.org/10.1039/D2BM01252A

Sawant, R. R., & Torchilin, V. P. (2012). Challenges in development of targeted liposomal therapeutics. AAPS Journal, 14, 303–315. https://doi.org/10.1208/s12248-012-9330-0 DOI: https://doi.org/10.1208/s12248-012-9330-0

Chen, T., He, B., Tao, J., He, Y., Deng, H., Wang, X., et al. (2019). Application of Förster resonance energy transfer (FRET) technique to elucidate intracellular and in vivo biofate of nanomedicines. Advanced Drug Delivery Reviews, 143, 177–205. https://doi.org/10.1016/j.addr.2019.04.009 DOI: https://doi.org/10.1016/j.addr.2019.04.009

Liu, D., Zhang, H., Fontana, F., Hirvonen, J. T., & Santos, H. A. (2018). Current developments and applications of microfluidic technology toward clinical translation of nanomedicines. Advanced Drug Delivery Reviews, 128, 54–83. https://doi.org/10.1016/j.addr.2017.08.003 DOI: https://doi.org/10.1016/j.addr.2017.08.003

Shrimal, P., Jadeja, G., & Patel, S. (2020). A review on novel methodologies for drug nanoparticle preparation: Microfluidic approach. Chemical Engineering Research and Design, 153, 728–756. https://doi.org/10.1016/j.cherd.2019.11.031 DOI: https://doi.org/10.1016/j.cherd.2019.11.031

Du, Z., Comer, J., & Li, Y. (2023). Bioinformatics approaches to discovering food-derived bioactive peptides: Reviews and perspectives. TrAC Trends in Analytical Chemistry, 162, 117051. https://doi.org/10.1016/j.trac.2023.117051 DOI: https://doi.org/10.1016/j.trac.2023.117051

Ghosh, R., Bera, R. D., & Chandra, S. (2024). An overview of bioinformatics and its application: A ray of hope towards microbial biotechnology. International Journal of Multidisciplinary Research, 6(1), 1–23. https://doi.org/10.36948/ijfmr.2024.v06i01.13726 DOI: https://doi.org/10.36948/ijfmr.2024.v06i01.13726

Diniz, W. J. d. S., & Canduri, F. (2017). Bioinformatics: An overview and its applications. Genetics and Molecular Research, 16(1), 17. https://doi.org/10.4238/gmr16019645 DOI: https://doi.org/10.4238/gmr16019645

Clark, A. J., & Lillard, J. W., Jr. (2024). A comprehensive review of bioinformatics tools for genomic biomarker discovery driving precision oncology. Genes (Basel), 15(8), 1036. https://doi.org/10.3390/genes15081036 DOI: https://doi.org/10.3390/genes15081036

Poetsch, A., & Li, Y. (2023). Multi-Omics data types and underlying technology. In Methodologies of Multi-Omics Data Integration and Data Mining: Techniques and Applications (Vol. 19, pp. 33). Springer. https://doi.org/10.1007/978-981-19-8210-1 DOI: https://doi.org/10.1007/978-981-19-8210-1_3

Hasin, Y., Seldin, M., & Lusis, A. (2017). Multi-omics approaches to disease. Genome Biology, 18(1), 1–15. https://doi.org/10.1186/s13059-017-1215-1 DOI: https://doi.org/10.1186/s13059-017-1215-1

Zhao, X., Zhao, H., Liu, Y., & Guo, Z. (2023). Methods, bioinformatics tools and databases in ecDNA research: An overview. Computers in Biology and Medicine, 167, 107680. https://doi.org/10.1016/j.compbiomed.2023.107680 DOI: https://doi.org/10.1016/j.compbiomed.2023.107680

Mustafa, M., Mohammed, A., Alzebair, A., & Makhawi, A. (2023). Integrating bioinformatics in drug discovery. Preprints. https://doi.org/10.20944/preprints202310.1465.v1 DOI: https://doi.org/10.20944/preprints202310.1465.v1

Xu, M., Xu, C., Chen, M., Xiao, Z., Wang, Y., Xu, Y., et al. (2023). Comparative analysis of commonly used bioinformatics software based on omics. Gene Reports, 32, 101800. https://doi.org/10.1016/j.genrep.2023.101800 DOI: https://doi.org/10.1016/j.genrep.2023.101800

Paananen, J., & Fortino, V. (2020). An omics perspective on drug target discovery platforms. Briefings in Bioinformatics, 21(6), 1937–1953. https://doi.org/10.1093/bib/bbz122 DOI: https://doi.org/10.1093/bib/bbz122

Reichel, A., & Lienau, P. (2016). Pharmacokinetics in drug discovery: An exposure-centred approach to optimising and predicting drug efficacy and safety. In New Approaches to Drug Discovery (pp. 235–260). Springer. https://doi.org/10.1007/164_2015_26 DOI: https://doi.org/10.1007/164_2015_26

Malathi, K., & Ramaiah, S. (2018). Bioinformatics approaches for new drug discovery: A review. Biotechnology and Genetic Engineering Reviews, 34(2), 243–260. https://doi.org/10.1080/02648725.2018.1502984 DOI: https://doi.org/10.1080/02648725.2018.1502984

Tanoli, Z., Seemab, U., Scherer, A., Wennerberg, K., Tang, J., & Vähä-Koskela, M. (2021). Exploration of databases and methods supporting drug repurposing: A comprehensive survey. Briefings in Bioinformatics, 22(2), 1656–1678. https://doi.org/10.1093/bib/bbaa003 DOI: https://doi.org/10.1093/bib/bbaa003

Amiri Souri, E., Chenoweth, A., Karagiannis, S. N., & Tsoka, S. (2023). Drug repurposing and prediction of multiple interaction types via graph embedding. BMC Bioinformatics, 24(1), 202. https://doi.org/10.1186/s12859-023-05317-w DOI: https://doi.org/10.1186/s12859-023-05317-w

Eugster, R., Orsi, M., Buttitta, G., Serafini, N., Tiboni, M., Casettari, L., Reymond, J.-L., Aleandri, S., & Luciani, P. (2024). Leveraging machine learning to streamline the development of liposomal drug delivery systems. Journal of Controlled Release, 376, 1025–1038. https://doi.org/10.1016/j.jconrel.2024.10.065 DOI: https://doi.org/10.1016/j.jconrel.2024.10.065

Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016). PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Advanced Drug Delivery Reviews, 99(Pt A), 28–51. https://doi.org/10.1016/j.addr.2015.09.012 DOI: https://doi.org/10.1016/j.addr.2015.09.012

Liu, P., Chen, G., & Zhang, J. (2022). A review of liposomes as a drug delivery system: Current status of approved products, regulatory environments, and future perspectives. Molecules, 27(4), 1372. https://doi.org/10.3390/molecules27041372 DOI: https://doi.org/10.3390/molecules27041372

Smits, E. A., Soetekouw, J. A., Pieters, E. H., Smits, C. J., de Wijs-Rot, N., & Vromans, H. (2019). The availability of drug by liposomal drug delivery: Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate. Investigational New Drugs, 37(5), 890–901. https://doi.org/10.1007/s10637-019-00788-8 DOI: https://doi.org/10.1007/s10637-018-0708-4

Bunker, A., Magarkar, A., & Viitala, T. (2021). Rational design of liposomal drug delivery systems using molecular dynamics simulations. Physical Chemistry Chemical Physics, 23(4), 2141–2157. https://doi.org/10.1039/D0CP05901A

Worsham, R. D., Thomas, V., & Farid, S. S. (2019). Potential of continuous manufacturing for liposomal drug products. Biotechnology Journal, 14(1), 1700740. https://doi.org/10.1002/biot.201700740 DOI: https://doi.org/10.1002/biot.201700740

Han, R., Ye, Z., Zhang, Y., Cheng, Y., Zheng, Y., & Ouyang, D. (2023). Predicting liposome formulations by the integrated machine learning and molecular modeling approaches. Asian Journal of Pharmaceutical Sciences, 18(4), 100811. https://doi.org/10.1016/j.ajps.2023.100811 DOI: https://doi.org/10.1016/j.ajps.2023.100811

Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017). Liposomal formulations in clinical use: An updated review. Pharmaceutics, 9(2), 12. https://doi.org/10.3390/pharmaceutics9020012 DOI: https://doi.org/10.3390/pharmaceutics9020012

FDA. (2018). Liposome drug products: Chemistry, manufacturing, and controls; human pharmacokinetics and bioavailability; and labeling documentation. U.S. Food and Drug Administration. https://www.fda.gov/media/70837/download

Jia, C., Zhang, Y., Wang, Y., Gao, J., Raza, A., Ogawa, T., … Wang, J. Y. (2023). Positively charged and neutral drug-loaded liposomes as aerosolized formulations for the efficiency assessment of tumor metastases to lungs. Journal of Drug Delivery Science and Technology, 80, 104081. https://doi.org/10.1016/j.jddst.2023.104081 DOI: https://doi.org/10.1016/j.jddst.2022.104081

Pisani, S., Di Martino, D., Cerri, S., Genta, I., Dorati, R., Bertino, G., Perteghella, S., Bruni, G., Modena, T., & Conti, B. (2023). Investigation and comparison of active and passive encapsulation methods for loading proteins into liposomes. International Journal of Molecular Sciences, 24(17), 13542. https://doi.org/10.3390/ijms241713542 DOI: https://doi.org/10.3390/ijms241713542

Aslam, M., Iqtedar, M., Saeed, H., Abdullah, R., & Kaleem, A. (2022). Formulation and characterization of ciprofloxacin encapsulated liposomes: In vitro antimicrobial activity against multidrug resistant Salmonella typhi. Revista Mexicana de Ingeniería Química, 21(2), Bio2734. https://doi.org/10.24275/rmiq/Bio2734 DOI: https://doi.org/10.24275/rmiq/Bio2734

Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications. Advanced Drug Delivery Reviews, 65(1), 36–48. https://doi.org/10.1016/j.addr.2012.09.037 DOI: https://doi.org/10.1016/j.addr.2012.09.037

Maja, L., Željko, K., & Mateja, P. (2020). Sustainable technologies for liposome preparation. The Journal of Supercritical Fluids, 165, 104984. https://doi.org/10.1016/j.supflu.2020.104984 DOI: https://doi.org/10.1016/j.supflu.2020.104984

Lu, H., Zhang, S., Wang, J., & Chen, Q. (2021). A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Frontiers in Nutrition, 8, Article 783831. https://doi.org/10.3389/fnut.2021.783831 DOI: https://doi.org/10.3389/fnut.2021.783831

Downloads

Published

2024-12-25

How to Cite

Aslam, M., Iftikhar , S., Amber, M., Amin, J., Yousaf, K., Ain, Q. ul, & Naz , E. (2024). Bridging Drug Delivery and Molecular Biology: A Synergistic Alliance between Liposomes and Bioinformatics. Journal of Microbiological Sciences, 3(01), 113–122. https://doi.org/10.38211/jms.2024.03.157

Most read articles by the same author(s)